The medical device maker has backed a series A round for InterVene, which hopes to treat a condition where veins are incapable of pumping enough blood to the heart.
US-based medical device developer InterVene closed the $5.9m first tranche of its series A funding yesterday led by medical device maker Boston Scientific.
The round also included North Texas Angels Network, venture capital firm Green Park and Golf Ventures, seed-stage investor LaunchCapital and unnamed angel investors.
InterVene is working on a treatment for chronic venous insufficiency, a medical condition where the veins are unable to pump back enough blood to the heart.
The condition can result in painful venous ulcers…
